Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CLINICAL RESPONSES TO ODRONEXTAMAB (REGN1979): CORRELATION WITH LOSS OF CD20 EXPRESSION AS A POTENTIAL MECHANISM OF RESISTANCE AND BASELINE BIOMARKERS OF TUMOR T CELLS

Hematological Oncology(2021)10.1002/hon.6_2880Source: DataRank Database

CLINICAL RESPONSES TO ODRONEXTAMAB (REGN1979): CORRELATION WITH LOSS OF CD20 EXPRESSION AS A POTENTIAL MECHANISM OF RESISTANCE AND BASELINE BIOMARKERS OF TUMOR T CELLS is a research paper published in Hematological Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Impact (FWCI 0.14)OA: bronzeTopics (20)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (24)

Nathalie Fiaschi ORCID,Raquel P. Deering ORCID,Ankur Dhanik ORCID,Kamil J. Cygan ORCID,W Zhang

Live enrichment

PubMed:23304386 OpenAlex:https://openalex.org/W3175029018

FWCI

0.14

Citation Percentile

0.4%

Citation Trend

2022

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.6_2880

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.6_2880

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.6_2880

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/hon.6_2880

journalhttps://doi.org/10.1002/hon.6_2880

Fields of Study

Lymphoma Diagnosis and TreatmentCAR-T cell therapy researchCancer Immunotherapy and Biomarkers

Keywords

CD20LymphomaMedicineImmunohistochemistryImmunofluorescenceRituximabPathologyDiffuse large B-cell lymphomaBiopsyCD19Follicular lymphomaMultiplexInternal medicineFlow cytometryAntibodyImmunologyBiology